NCT01478529View on ClinicalTrials.gov

A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Pharmacokinetics of MirabegronBioavailabilityHealthy Subjects
Interventions
DRUG

mirabegron OCAS

oral administration

DRUG

mirabegron

iv administration

Trial Locations (1)

9470 AE

Pharma Bio Research, Zuidlaren

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY